ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
ProSomnus Inc

ProSomnus Inc (OSA)

0.47
0.00
( 0.00% )
Updated: 20:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.47
Bid
0.485
Ask
0.5998
Volume
-
0.00 Day's Range 0.00
0.34505 52 Week Range 4.89
Market Cap
Previous Close
0.47
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
36,492
Shares Outstanding
16,398,599
Dividend Yield
-
PE Ratio
-0.32
Earnings Per Share (EPS)
-1.47
Revenue
27.65M
Net Profit
-24.1M

About ProSomnus Inc

Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep ... Prosomnus Inc is a company engaged in the research of dental medical technology. The Company is principally engaged in the development, manufacture and marketing of precision intraoral medical devices. The Company's products include MicrO2 Sleep and Snore Device, IA Sleep and Snore Device, CA Sleep and Snore Device, PH Sleep and Snore Device and EVO Sleep and Snore Device, which are used in the treatment and management of mild to moderate obstructive sleep apnea disease. The Company's precision intraoral devices are personalized to each patient's anatomy and treatment plan. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
ProSomnus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker OSA. The last closing price for ProSomnus was $0.47. Over the last year, ProSomnus shares have traded in a share price range of $ 0.34505 to $ 4.89.

ProSomnus currently has 16,398,599 shares outstanding. The market capitalization of ProSomnus is $7.71 million. ProSomnus has a price to earnings ratio (PE ratio) of -0.32.

OSA Latest News

ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial...

Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks

In Monday’s pre-market trading, U.S. index futures are mixed, with Wall Street in anticipation of the monetary policy guidelines that the Federal Reserve is expected to release during the...

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has...

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot...

ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024

PLEASANTON, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea (OSA), announced today that it will...

ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

PLEASANTON, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today that the United...

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is...

ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea

PLEASANTON, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, welcomes the adoption of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12-0.1821-27.9251648520.65210.65510.47364920.57683319CS
26-0.192-29.0030211480.6621.360.461613916970.97181715CS
52-4.31-90.16736401674.784.890.345056054750.97375691CS
156-6.6-93.35219236217.079.410.345053802641.01426306CS
260-6.6-93.35219236217.079.410.345053802641.01426306CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 4.889
(259.49%)
36.2M
SVMHSRIVARU Holding Ltd
$ 0.323
(111.80%)
194.14M
CNSPCNS Pharmaceuticals Inc
$ 6.99
(93.09%)
2.9M
TOIIWOncology Institute Inc
$ 0.035
(92.31%)
35.55k
LGVNLongeveron Inc
$ 3.74
(39.03%)
58.46M
QXOQXO Inc
$ 135.3429
(-34.11%)
94.8k
NXLNexalin Technologies Inc
$ 0.9175
(-33.53%)
2.54M
GANXGain Therapeutics Inc
$ 1.28
(-32.28%)
1.8M
INABIN8bio Inc
$ 1.17
(-30.36%)
2.18M
KYTXKyverna Therapeutics Inc
$ 10.605
(-26.56%)
1.82M
SVMHSRIVARU Holding Ltd
$ 0.3201
(109.90%)
194.24M
NVDANVIDIA Corporation
$ 131.2201
(1.24%)
113.25M
LGVNLongeveron Inc
$ 3.67
(36.43%)
58.54M
KITTNauticus Robotics Inc
$ 0.1817
(13.21%)
45.72M
SQQQProShares UltraPro Short QQQ
$ 8.5303
(-0.11%)
41.24M

Your Recent History

Delayed Upgrade Clock